Merck & Co Inc (NYSE:MRK)

108.83
Delayed Data
As of Nov 29
 +0.38 / +0.35%
Today’s Change
71.50
Today|||52-Week Range
109.06
+42.00%
Year-to-Date
At All-Time Highs, Merck's Stock Is Nearing a Cliff
Nov 29 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights Archer-Daniels-Midland, McKesson, Marathon Petroleum, Exxon Mobil and Merck & Co
Nov 23 / Zacks.com - Paid Partner Content
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?
Nov 29 / Zacks.com - Paid Partner Content
Encompass Health (EHC) Proposes 50-Bed Hospital in Florida
Nov 22 / Zacks.com - Paid Partner Content
Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?
Nov 29 / Zacks.com - Paid Partner Content
Imago (IMGO) Shares Surge 104% on Buyout Offer From Merck
Nov 22 / Zacks.com - Paid Partner Content
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
Nov 29 / MotleyFool.com - Paid Partner Content
Buy These 5 Corporate Giants Flying High in Disappointing 2022
Nov 22 / Zacks.com - Paid Partner Content
Is Merck & Co. Stock Worth Buying Before the End of 2022?
Nov 29 / StockNews.com - Paid Partner Content
AbbVie (ABBV) BLA for Epcoritamab Gets FDA Priority Tag
Nov 22 / Zacks.com - Paid Partner Content
Factors That Make Elevance Health (ELV) a Lucrative Bet Now
Nov 28 / Zacks.com - Paid Partner Content
Iovance (IOVA) Extends Timeline for Rolling BLA of Melanoma Drug
Nov 21 / Zacks.com - Paid Partner Content
Should Value Investors Buy Innoviva (INVA) Stock?
Nov 28 / Zacks.com - Paid Partner Content
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
Nov 21 / MotleyFool.com - Paid Partner Content
Merck & Co., Inc. (MRK) Hits Fresh High: Is There Still Room to Run?
Nov 28 / Zacks.com - Paid Partner Content
Is Merck & Co. (MRK) Outperforming Other Medical Stocks This Year?
Nov 21 / Zacks.com - Paid Partner Content
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Nov 28 / MotleyFool.com - Paid Partner Content
Pfizer (PFE), BioNTech Provide New Data on BA.4/BA.5 Boosters
Nov 21 / Zacks.com - Paid Partner Content
3 Stocks Insiders Can’t Stop Buying This Month
Nov 28 / StockNews.com - Paid Partner Content
2 Top Biotech Stocks to Buy Right Now
Nov 19 / MotleyFool.com - Paid Partner Content
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
Nov 25 / Zacks.com - Paid Partner Content
3 Bargain Stocks You Can Buy Today and Hold Forever
Nov 18 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indication
Nov 25 / Zacks.com - Paid Partner Content
Sanofi's (SNY) Rare Anemia Drug Enjaymo Gets EU Approval
Nov 18 / Zacks.com - Paid Partner Content
4 Stocks to Buy That Have Caught Wall Street's Attention
Nov 24 / StockNews.com - Paid Partner Content
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo
Nov 18 / Zacks.com - Paid Partner Content
Novartis (NVS) Set to Advance Malaria Drug Into Phase III
Nov 24 / Zacks.com - Paid Partner Content
Merck (MRK) Outpaces Industry YTD: What's in Store for 2023?
Nov 17 / Zacks.com - Paid Partner Content
Mirati's (MRTX) Stock Rallies 11% on Buyout Speculations
Nov 24 / Zacks.com - Paid Partner Content
Novartis (NVS) Reportedly Looking to Sell Its Business Units
Nov 17 / Zacks.com - Paid Partner Content
AbbVie's (ABBV) Skyrizi Gets EU Nod for Crohn's Disease
Nov 24 / Zacks.com - Paid Partner Content
How Long Can This Top Stock Continue Defying the Bear Market?
Nov 17 / MotleyFool.com - Paid Partner Content
2 Stocks the Smart Money on Wall Street Owns the Majority Right Now
Nov 24 / StockNews.com - Paid Partner Content
4 Reasons to Buy This Hybrid of a Growth and Income Stock
Nov 17 / MotleyFool.com - Paid Partner Content
Merck (MRK) Keytruda Advanced Gastric Cancer Study Meets Goal
Nov 23 / Zacks.com - Paid Partner Content
Dow has biggest monthly gain in more than 45 years
Oct 31 / CNN.com
GSK to Withdraw Blenrep From U.S. Market on FDA Request
Nov 23 / Zacks.com - Paid Partner Content